# Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19

> **NCT05386446** · — · COMPLETED · sponsor: **SPP Pharmaclon Ltd.** · enrollment: 100 (actual)

## Conditions studied

- COVID-19 Respiratory Infection

## Interventions

- **DRUG:** Interferon gamma human recombinant (IFN-G)

## Key facts

- **NCT ID:** NCT05386446
- **Lead sponsor:** SPP Pharmaclon Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-23
- **Primary completion:** 2020-06-10
- **Final completion:** 2020-06-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05386446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05386446, "Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05386446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*